![Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/99590a94-40e5-47cb-b268-379b1f648d1d/gr2.jpg)
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine
American College of Chest Physicians - In a real-world setting, LAMA-LABA- ICS is as effective as LAMA-LABA to prevent COPD exacerbations, but incidence of pneumonia increased with triple therapy initiation: https://hubs.ly/H0pPLQ20 | Facebook
![Algorithm for withdrawal of ICS in symptomatic patients with COPD. a... | Download Scientific Diagram Algorithm for withdrawal of ICS in symptomatic patients with COPD. a... | Download Scientific Diagram](https://www.researchgate.net/publication/326206557/figure/fig1/AS:645018255642634@1530795744549/Algorithm-for-withdrawal-of-ICS-in-symptomatic-patients-with-COPD-a-Note-a-If.png)
Algorithm for withdrawal of ICS in symptomatic patients with COPD. a... | Download Scientific Diagram
![Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213219818300904-gr1.jpg)
Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect
![Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice - ScienceDirect Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0012369219342254-gr1.jpg)
Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice - ScienceDirect
![Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/14237d6f07c90838ca1277212ca4bae185748743/3-Figure1-1.png)
Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar
![Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0012369219300145-gr1.jpg)
Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect
![Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X](https://pbs.twimg.com/media/DtzVlWsWwAArrfB.jpg)
Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X
![Full article: A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid Full article: A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid](https://www.tandfonline.com/action/showGraphicalAbstractImage?doi=10.2147%2FCOPD.S350167&id=dcop_a_12164092_uf0001_c.jpg)
Full article: A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
![Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/410388bf4ca6316b0fbca72a61ab191f5ae501af/7-Figure2-1.png)
Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
![Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología](https://static.elsevier.es/multimedia/03002896/0000005800000010/v2_202302271800/S0300289622003374/v2_202302271800/en/main.assets/gr1.jpeg)
Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología
![Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41533-020-00205-9/MediaObjects/41533_2020_205_Fig1_HTML.png)
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
![JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations](https://www.mdpi.com/jcm/jcm-11-06623/article_deploy/html/images/jcm-11-06623-g001.png)
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
![Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41533-023-00347-6/MediaObjects/41533_2023_347_Fig1_HTML.png)
Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine
![Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/cf7c63e7-298c-40aa-ace2-39bf59630ff1/gr1.gif)
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine
![Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis | Respiratory Research | Full Text Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis | Respiratory Research | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12931-021-01777-x/MediaObjects/12931_2021_1777_Fig6_HTML.png)